Tryptophan fluorescence quenching in β-lactam-interacting proteins is modulated by the structure of intermediates and final products of the acylation reaction
S. Triboulet, Z. Edoo, F. Compain, C. Ourghanlian, A. Dupuis, V. Dubee, L. Sutterlin, H. Atze, M. Etheve-Quelquejeu, J.-E. Hugonnet, M. Arthur
Abstract
In most bacteria, {beta}-lactam antibiotics inhibit the last cross-linking step of peptidoglycan synthesis by acylation of the active-site Ser of D,D-transpeptidases belonging to the penicillin-binding protein (PBP) family. In mycobacteria, cross-linking is mainly ensured by L,D-transpeptidases (LDTs), which are promising targets for the development of {beta}-lactam-based therapies for multidrug-resistant tuberculosis. For this purpose, fluorescence spectroscopy is used to investigate the efficacy of LDT inactivation by {beta}-lactams but the basis for fluorescence quenching during enzyme acylation remains unknown. In contrast to what has been reported for PBPs, we show here using a model L,D-transpeptidase (Ldtfm) that fluorescence quenching of Trp residues does not depend upon direct hydrophobic interaction between Trp residues and {beta}-lactams. Rather, Trp fluorescence was quenched by the drug covalently bound to the active-site Cys residue of Ldtfm. Fluorescence quenching was not quantitatively determined by the size of the drug and was not specific of the thioester link connecting the {beta}-lactam carbonyl to the catalytic Cys as quenching was also observed for acylation of the active-site Ser of {beta}-lactamase BlaC from M. tuberculosis. Fluorescence quenching was extensive for reaction intermediates containing an amine anion and for acylenzymes containing an imine stabilized by mesomeric effect, but not for acylenzymes containing a protonated {beta}-lactam nitrogen. Together, these results indicate that the extent of fluorescence quenching is determined by the status of the {beta}-lactam nitrogen. Thus, fluorescence kinetics can provide information not only on the efficacy of enzyme inactivation but also on the structure of the covalent adducts responsible for enzyme inactivation.
02 /Specification & Classification
Click any tag to browse matching papers- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Investigating β-lactam drug targets in Mycobacterium tuberculosis using chemical probes
K. E. Beatty, S. R. Levine·bioRxiv·Dec 19, 2019
- Targeting Mycobacterial Transpeptidases: Evaluating the Roles of Ldt and PBP Inhibition in Suppressing Mycobacterium smegmatis
Mariska de Munnik, Karina Calvopiña, … Christopher John Schofield·Antimicrobial Agents and ChemotherapyPeer-reviewed·Sep 15, 2025
- Allosteric cooperation in β-lactam binding to a non-classical transpeptidase
N. Ahmad, S. Kachhap, … P. Kumar·eLifePeer-reviewed·Apr 27, 2022
- Molecular docking, validation, dynamic simulation and pharmacokinetic prediction of natural compounds against Mycobacterium tuberculosis Beta-lactamase BlaC
Sandra Sreekumar, J.L Bhagya Jyothi, … Immanuel Dhanasingh·bioRxiv·Jan 7, 2025
- Methyl substituted β-lactam framework based antibiotics and β-lactamase inhibitors: Proof of concept by computations
Vaishali Thakkur, Chandan Kumar Das, … Nisanth N. Nair·bioRxiv·Jan 14, 2024
- Comprehensive identification of β-lactam antibiotic polypharmacology in Mycobacterium tuberculosis
Kaylyn L. Devlin, Emily Hutchinson, … Kimberly E. Beatty·ACS Infectious DiseasesPeer-reviewed·Aug 18, 2025